Literature DB >> 26261649

Association between MDM2 rs769412 and rs937283 polymorphisms with alcohol drinking and laryngeal carcinoma risk.

Hongzeng Wang1, Kunpeng Ma1.   

Abstract

TARGET: To investigate the association between the interactions of murine double minute 2 (MDM2) polymorphisms (rs769412 and rs937283) with alcohol drinking and laryngeal carcinoma.
METHODS: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to detect the genotypes status of MDM2 rs769412 and rs937283 polymorphisms among 126 cases and 120 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by the chi-squared test, which was adopted to analyze the association between MDM2 rs769412 and rs937283 polymorphisms and the susceptibility to larynx carcinoma in the drinking population.
RESULTS: Genotypes distributions of MDM2 rs769412 and rs937283 polymorphisms in the control group were in accordance with Hardy-Weinberg equilibrium (HWE). MDM2 rs769412 GG genotype and G allele significantly increased laryngeal carcinoma risk (GG vs. AA: OR=3.17, 95% CI=1.25-8.04; G vs. A: OR=1.88, 95% CI=1.24-2.84). Furthermore, the mutant genotypes of MDM2 rs937283and rs769412 were remarkablely associated with the increased risk for laryngeal carcinoma in drinking population (rs937283: OR=2.67, 95% CI=1.40-5.07; rs769412: OR=3.76, 95% CI=1.62-8.75).
CONCLUSION: MDM2 polymorphisms are correlated with the onset of laryngeal carcinoma. The relationship is strengthened by alcohol drinking.

Entities:  

Keywords:  Laryngeal carcinoma; MDM2; alcohol drinking; polymorphisms

Mesh:

Substances:

Year:  2015        PMID: 26261649      PMCID: PMC4525983     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer.

Authors:  A F Olshan; M C Weissler; M A Watson; D A Bell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-02       Impact factor: 4.254

Review 2.  Biological characterization of laryngeal squamous-cell carcinoma.

Authors:  R M Tomasino; V Bazan; E Daniele; R Nuara; V Morello; V Tralongo; G Leto; A Russo
Journal:  Anticancer Res       Date:  1996 Jul-Aug       Impact factor: 2.480

3.  Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus.

Authors:  Yan Cui; Hal Morgenstern; Sander Greenland; Donald P Tashkin; Jenny Mao; Wei Cao; Wendy Cozen; Thomas M Mack; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2006-02-01       Impact factor: 7.396

4.  Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility.

Authors:  B Chen; M-M Xiong; X-L Meng
Journal:  Dis Esophagus       Date:  2014-05-20       Impact factor: 3.429

5.  Second neoplasm in patients with head and neck cancer.

Authors:  X León; M Quer; S Diez; C Orús; A López-Pousa; J Burgués
Journal:  Head Neck       Date:  1999-05       Impact factor: 3.147

6.  Impact of the Mdm2(SNP309-G) allele on a murine model of colorectal cancer.

Authors:  X Zhang; L Pageon; S M Post
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

7.  Studies on expression of p14ARF and MDM2 in human thyroid neoplasms.

Authors:  X W Qi; H R Wu; Y Yin; S H Xia; J J Feng; Y Pu; L F Jin
Journal:  Panminerva Med       Date:  2014-11-11       Impact factor: 5.197

8.  TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.

Authors:  Rym Abderrahmane; Lotfi Louhibi; Fatima Zohra Moghtit; Amina Boubekeur; Khedidja Benseddik; Abdellah Boudjema; Fouzia Benrrahal; Meriem Aberkane; Mostefa Fodil; Nadhira Saidi-Mehtar
Journal:  Pathol Oncol Res       Date:  2014-12-24       Impact factor: 3.201

9.  A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

Authors:  Gareth L Bond; Wenwei Hu; Elisabeth E Bond; Harlan Robins; Stuart G Lutzker; Nicoleta C Arva; Jill Bargonetti; Frank Bartel; Helge Taubert; Peter Wuerl; Kenan Onel; Linwah Yip; Shih-Jen Hwang; Louise C Strong; Guillermina Lozano; Arnold J Levine
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

Review 10.  Functions of the MDM2 oncoprotein.

Authors:  D A Freedman; L Wu; A J Levine
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

View more
  5 in total

1.  Association of genetic polymorphisms with laryngeal carcinoma prognosis in a Chinese population.

Authors:  Fang Quan; Feipeng Zhang; Yanxia Bai; Long Zhou; Hua Yang; Bin Li; Tianbo Jin; Huajing Li; Yuan Shao
Journal:  Oncotarget       Date:  2017-02-07

2.  Association between tobacco substance usage and a missense mutation in the tumor suppressor gene P53 in the Saudi Arabian population.

Authors:  Mikhlid H Almutairi; Bader O Almutairi; Turki M Alrubie; Sultan N Alharbi; Narasimha R Parine; Abdulwahed F Alrefaei; Ibrahim Aldeailej; Abdullah Alamri; Abdelhabib Semlali
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

3.  Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals.

Authors:  Xianlu Zhuo; Huiping Ye; Qi Li; Zhaolan Xiang; Xueyuan Zhang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

4.  A Functional Polymorphism (rs937283) in the MDM2 Promoter Region is Associated with Poor Prognosis of Retinoblastoma in Chinese Han Population.

Authors:  Yongfa Jiao; Zhongming Jiang; Yuxia Wu; Xiaochong Chen; Xing Xiao; Haiying Yu
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

5.  The Study of MDM2 rs937283 Variant and Cancer Susceptibility in a Central Chinese Population.

Authors:  Bifeng Chen; Jingdong Wang; Jieling Wang; Jingli Zhang; Xiuli Gu; Xianhong Feng
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.